Bosulif
Bosutinib · Pfizer Laboratories Div Pfizer Inc
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Bosulif ingredients
| Active ingredient | Strength |
|---|---|
| Bosutinib Monohydrate | 400 mg/1, 50 mg/1, 100 mg/1, 500 mg/1 |
What Bosulif is used for
Bosulif is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Bosulif
- Generic name
- Bosutinib
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Capsule, Tablet, Film Coated
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA203341
- On the US market since
- 2012
Official information
- Bosulif prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Bosutinib)
In India
- Bosutinib monohydrate: 5 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Bosulif?
Bosulif (Bosutinib) is a cancer medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Bosulif?
Bosulif contains Bosutinib Monohydrate (400 mg/1, 50 mg/1, 100 mg/1, 500 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA